Navigation Links
ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy
Date:8/19/2014

NEW YORK, Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick J. Treado, PhD, will present a scientific poster describing an innovative diagnostic procedure for the detection of colorectal cancer during the SPEC 2014: Shedding New Light on Disease (SPEC) conference in Krakow, Poland.

Dr. Treado's poster entitled, "Development of in vitro Diagnostics for Detection of Colorectal Cancer Using Raman Molecular Imaging" will be discussed during the conference poster session on Tuesday, August 19, 2014 from 6:30 – 8:00pm.  The scientific poster presents the results of a study performed by scientists at ChemImage, in collaboration with urology and gastroenterology clinicians, on the development of in vitro diagnostic (IVD) Raman assays focused on colorectal cancer detection. The results of these ongoing clinical studies will be presented including discussion of the study design, the underlying basis of discrimination and advantages provided by RMI.

"I am very excited to present our findings at 2014 SPEC," said Patrick J. Treado, Chief Technology Officer at ChemImage. "I look forward to sharing the results of our research with thought leaders in the Raman spectroscopy community."

SPEC 2014 is an international conference series aiming to bring together clinicians and scientists who have joined forces in the quest for novel biomedical applications of Infrared and Raman spectroscopy to improve patient care. Due to its unique fingerprinting capability, Raman spectroscopy plays a significant role in histopathology, cytology, biopsy targeting, surgical targets, and treatment monitoring and drug studies. The conference highlights further advances in state of the art and emerging biomedical applications of Raman Spectroscopy, while critically reviewing the challenges in the context of other emerging technologies.

For more information regarding ChemImage's Raman chemical imaging capabilities, contact Patrick Treado at treado@chemimage.com.

About ChemImage

ChemImage Corporation, a leader in hyperspectral and Raman chemical imaging technology provides innovative instrumentation, analysis software, contract services and expert consulting to government, industrial and academic organizations. The company's proprietary, state-of-the-art imaging technology has many applications, including defense, security, pharmaceuticals, forensics and biomedical diagnostic research, which can reveal critical chemical and biological information from a variety of material systems.

ChemImage's headquarters are located in Pittsburgh, PA, where it pioneers research and development, as well as providing engineering and manufacturing which develops innovative products for the global marketplace.

Media Contact: Tifanie Tiberio, ChemImage Corporation, 412-241-7335 ext. 269, tiberiot@chemimage.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ChemImage Corporation
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014
2. Scientists at HerbalScience Develop a Synergistic Method to Fight Antibiotic Resistant Bacteria
3. Made in IBM Labs: Scientists Turn Data into Disease Detective to Predict Dengue Fever and Malaria Outbreaks
4. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
5. New Workflow to Provide Scientists with Tools That Enable Single Cell Analysis for Oncology, Immunology and Stem Cell Research
6. NYU-Poly Nano Scientists Reach the Holy Grail in Label-Free Cancer Marker Detection: Single Molecules
7. From Autism to Diabetes to Parkinsons Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
8. Tucson Symposium attracts over 450 global scientists focused on personalized healthcare
9. Janssen Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
10. Harrington Discovery Institute at University Hospitals Case Medical Center Announces Grant Funding to Physician-Scientists at Major Academic Medical Centers to Support New Drug Development
11. South Korean lawmakers one step from rigorous new system for stem cell Advancement: scientists, physicians and patients applaud, urge lawmakers to complete The Job
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... are expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) ... greater use of this type of healthcare model in the diagnosis and treatment ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 ... an educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd ... approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate ... Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, ... the Board of Directors for CONTACT USA, and former member of the American Association ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic ... manufacture its ANCD BRAIN device as the product advances towards regulatory and clinical ...
Breaking Medicine News(10 mins):